Key Quantitative Figures

Financial Results for Year Ended 31st March 2026:

  • Total Revenue: ₹1,61,388.41 lakhs (FY25: ₹1,39,321.72 lakhs)
  • Profit Before Tax: ₹32,569.14 lakhs (FY25: ₹27,755.36 lakhs)
  • Net Profit: ₹24,446.00 lakhs (FY25: ₹20,894.62 lakhs)
  • Basic & Diluted EPS: ₹223.41 (FY25: ₹190.95)
  • Total Comprehensive Income: ₹24,404.52 lakhs (FY25: ₹20,856.61 lakhs)

Quarter Ended 31st March 2026:

  • Total Revenue: ₹42,167.02 lakhs
  • Profit Before Tax: ₹8,427.80 lakhs
  • Net Profit: ₹5,968.60 lakhs
  • Basic & Diluted EPS: ₹54.55

Segment Revenue FY26:

  • Healthcare: ₹1,47,024.61 lakhs
  • Education: ₹11,539.07 lakhs

Balance Sheet Position as of 31st March 2026:

  • Total Assets: ₹2,06,608.11 lakhs
  • Total Equity: ₹1,31,926.52 lakhs
  • Current Assets: ₹42,093.79 lakhs
  • Cash & Cash Equivalents: ₹6,372.38 lakhs

Cash Flow FY26:

  • Net cash from operating activities: ₹36,183.43 lakhs
  • Net cash used in investing activities: ₹(23,018.48) lakhs
  • Net cash used in financing activities: ₹(5,836.97) lakhs

Dates of Action

  • Board Meeting: 22nd May 2026 (commenced at 4:00 PM, concluded at 6:12 PM)
  • Record Date for Dividend: 19th August 2026
  • 40th Annual General Meeting: 26th August 2026
  • Book Closure: 20th August 2026 to 26th August 2026 (both days inclusive)
  • Cut-off date for e-voting/AGM eligibility: 19th August 2026

Parties Involved

  • Statutory Auditors: VKS Aiyer & Co., Chartered Accountants (FRN: 0000665)
  • Cost Auditor: Mr. V. Sakthivel, Cost Accountant (Membership No. 23292) of M/s RKMS & Associates
  • Internal Auditor: Mr. G. Jawaharlal, Chartered Accountant
  • Managing Director: Dr. Nalla G Palaniswami (DIN: 00013536)

Dividend Information

  • Final dividend recommended: 150% on equity capital (₹15 per share of face value ₹10)
  • Dividend subject to shareholder approval at ensuing AGM
  • Total dividend payout not quantified in disclosure

Capital Structure Impact

  • Equity Share Capital remains unchanged at ₹1,094.23 lakhs
  • Dividend recommendation represents return to shareholders without capital structure alteration

Financial Impact Assessment

All financial impacts are quantified and presented in the audited results. No contingent exposures or subject-to-approval outcomes disclosed beyond the dividend recommendation requiring shareholder approval.